UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription

Proceedings of the National Academy of Sciences - PNAS, 2002-09, Vol.99 (18), p.11593-11598

2002

Volltextzugriff (PDF)

Different expression of placental pyruvate kinase in normal, preeclamptic and intrauterine growth restriction pregnancies

Placenta (Eastbourne), 2014-11, Vol.35 (11), p.883-890

2014

Volltextzugriff (PDF)

P-411 Pancreatic cancer oral inverse agonist of RORgT receptor targets primary cancer cells and alters inflammatory mediators of the tumor microenvironment

Annals of oncology, 2023-06, Vol.34, p.S157-S157

2023

Volltextzugriff (PDF)

Transcriptional Repression by YY1 is Mediated by Interaction with a Mammalian Homolog of the Yeast Global Regulator RPD3

Proceedings of the National Academy of Sciences - PNAS, 1996-11, Vol.93 (23), p.12845-12850

1996

Volltextzugriff (PDF)

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response

Leukemia, 2014-11, Vol.28 (11), p.2251-2254

2014

Volltextzugriff (PDF)

Sensitization of a Glioblastoma Multiforme (GBM) Cell Line by MP470: A Novel c-Met Antagonist

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S100-S100

2007

Volltextzugriff (PDF)

Mutations in the G-Quadruplex Silencer Element and Their Relationship to c-MYC Overexpression, NM23 Repression, and Therapeutic Rescue

Proceedings of the National Academy of Sciences - PNAS, 2004-04, Vol.101 (16), p.6140-6145

2004

Volltextzugriff (PDF)

Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer

The Journal of biological chemistry, 1998-08, Vol.273 (32), p.20448-20455

1998

Volltextzugriff (PDF)

A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis

Molecular and Cellular Biology, 1998-01, Vol.18 (1), p.85-92

1998

Volltextzugriff (PDF)

Erratum: Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

Oncogene, 2016-11, Vol.35 (47), p.6155-6156

2016

Volltextzugriff (PDF)

460PA phase Ia/b first-in-human, open-label, dose-escalation, safety, PK and PD study of TP-0903 in solid tumours

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Highly effective combination of LSD1

Leukemia, 2017-07, Vol.31 (7), p.1658

2017

Volltextzugriff (PDF)

Erratum: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

Leukemia, 2017-07, Vol.31 (7), p.1658-1658

2017

Volltextzugriff (PDF)

332 POSTER In vivo activity of SGI-1776, an orally active Pim kinase inhibitor

European journal of cancer supplements, 2008, Vol.6 (12), p.105-106

2008

Volltextzugriff (PDF)

341 Targeting NEK2 kinase in drug resistant multiple myeloma with small molecule inhibitors

European journal of cancer supplements, 2010, Vol.8 (7), p.109-109

2010

Volltextzugriff (PDF)

PF285 ZELLA‐101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML PATIENTS

HemaSphere, 2019-06, Vol.3 (S1), p.94-n/a

2019

Volltextzugriff (PDF)

Abstract P2-06-05: TP-0903, an AXL kinase inhibitor, reduces inflammatory breast cancer aggressiveness and macrophage polarization through additional mechanisms that may include JAK2 and Aurora B

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-06-05

2019

Volltextzugriff (PDF)

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-x sub(L) dependence with alvocidib response

Leukemia, 2014-11, Vol.28 (11), p.2251-2254

2014

Volltextzugriff (PDF)

Telomere inhibition and telomere disruption as processes for drug targeting

Annual review of pharmacology and toxicology, 2003-01, Vol.43 (1), p.359-379

2003

Volltextzugriff (PDF)

Aurora-A over-expression in high-grade PIN lesions and prostate cancer

The Prostate, 2005-09, Vol.64 (4), p.341-346

2005

Volltextzugriff (PDF)

Telomeres and telomerases as drug targets

Current Opinion in Pharmacology, 2002-08, Vol.2 (4), p.415-423

2002

Volltextzugriff (PDF)

Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction

Bioorganic & medicinal chemistry letters, 2004-11, Vol.14 (21), p.5377-5381

2004

Volltextzugriff (PDF)

α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells

Cancer Immunology, Immunotherapy, 2004-07, Vol.53 (7), p.580-588

2004

Volltextzugriff (PDF)

Harnessing virtual screening for the targeted discovery of cisplatin adjuvants from marine invertebrates

Planta medica, 2012, Vol.78 (11)

2012

Volltextzugriff (PDF)

413 POSTER Discovery and characterization of a series of Axl kinase inhibitors using the CLIMB process

European journal of cancer supplements, 2006-11, Vol.4 (12), p.127-127

2006

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(98)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription

Different expression of placental pyruvate kinase in normal, preeclamptic and intrauterine growth restriction pregnancies

P-411 Pancreatic cancer oral inverse agonist of RORgT receptor targets primary cancer cells and alters inflammatory mediators of the tumor microenvironment

Transcriptional Repression by YY1 is Mediated by Interaction with a Mammalian Homolog of the Yeast Global Regulator RPD3

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response

Sensitization of a Glioblastoma Multiforme (GBM) Cell Line by MP470: A Novel c-Met Antagonist

Mutations in the G-Quadruplex Silencer Element and Their Relationship to c-MYC Overexpression, NM23 Repression, and Therapeutic Rescue

Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer

A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis

Erratum: Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

460PA phase Ia/b first-in-human, open-label, dose-escalation, safety, PK and PD study of TP-0903 in solid tumours

Highly effective combination of LSD1

Erratum: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

332 POSTER In vivo activity of SGI-1776, an orally active Pim kinase inhibitor

341 Targeting NEK2 kinase in drug resistant multiple myeloma with small molecule inhibitors

PF285 ZELLA‐101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML PATIENTS

Abstract P2-06-05: TP-0903, an AXL kinase inhibitor, reduces inflammatory breast cancer aggressiveness and macrophage polarization through additional mechanisms that may include JAK2 and Aurora B

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-x sub(L) dependence with alvocidib response

Telomere inhibition and telomere disruption as processes for drug targeting

Aurora-A over-expression in high-grade PIN lesions and prostate cancer

Telomeres and telomerases as drug targets

Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction

α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells

Harnessing virtual screening for the targeted discovery of cisplatin adjuvants from marine invertebrates

413 POSTER Discovery and characterization of a series of Axl kinase inhibitors using the CLIMB process

Aktive Filter

Suchergebnisse filtern